A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors
Clinical trial NCT03355066 · TERMINATED
Trial details
- NCT number
- NCT03355066
- Sponsor
- Biosplice Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-06
- Primary completion
- 2022-11-14
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.